Bupivacaine HCL 0.75% Injection, 10 mL Single-Dose Vial, 25 Vials/Pack

Bupivacaine Hydrochloride — 0.75%, Solution for injection, carton of 25 × 10 mL vials

Bupivacaine Hydrochloride is a solution for injection for epidural; retrobulbar use. Bupivacaine hydrochloride injection is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Specific concentrations and presentations of bupivacaine hydrochloride injection are recommended for each type of block indicated to produce local or regional anesthesia or analgesia [see Dosage and Administration (2.2) ].

• Active ingredient or product type: BUPIVACAINE HYDROCHLORIDE
• Strength/concentration: 0.75%
• Dosage form and route: Solution for injection, Epidural; Retrobulbar
• Exact package presentation: carton of 25 × 10 mL vials
• NDC/item number: 55150-171-10
• Manufacturer: EUGIA US LLC
• Storage/handling: Protect from light. Discard unused portion. Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
• Status: Rx only

Important safety information: Dose-Related Toxicity : Monitor cardiovascular and respiratory vital signs and patient’s state of consciousness after injection of bupivacaine hydrochloride. ( 5.2 ) Methemoglobinemia : Cases of methemoglobinemia have been reported in association with local anesthetic use.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.